Literature DB >> 17998022

The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with increased small dense low-density lipoprotein in a rural Japanese population: the Mima study.

Kokoro Tsuzaki1, Kazuhiko Kotani, Shinji Fujiwara, Yoshiko Sano, Yukiyo Matsuoka, Masayuki Domichi, Taku Hamada, Akira Shimatsu, Naoki Sakane.   

Abstract

The presence of small dense low-density lipoprotein (sdLDL) is closely associated with an increased risk of developing coronary artery disease. The Trp64Arg polymorphism of the beta(3)-adrenergic receptor (beta(3)-AR) gene is a genetic marker for obesity-related traits. However, any possible association between this polymorphism and sdLDL profiles is unclear. The objective of this study is to investigate the effects of the polymorphism of the beta(3)-AR gene on LDL particle size and sdLDL in a rural Japanese population. Among 277 subjects, body mass index, blood pressure, fasting serum insulin levels, and insulin resistance index (fasting glucose x fasting insulin/405) were determined. The polymorphism of the beta(3)-AR gene was assessed by polymerase chain reaction-restriction fragment length polymorphism using buccal samples. Low-density lipoprotein particle size and sdLDL were measured with the electrophoretic separation of lipoproteins on the LipoPrint System (Quantimetrix, Redondo Beach, CA). The frequency of the beta(3)-AR allele was 0.19. In Arg carriers (Trp/Arg or Arg/Arg), the mean value of LDL particle size was smaller than that of non-Arg carriers (Trp/Trp) (P < .05). The area percentage of sdLDL was higher in Arg carriers (P < .05) than in non-Arg carriers. A multiple regression analysis showed that the area percentage of sdLDL was correlated with the polymorphism of the beta(3)-AR gene (P < .05), independently of age, sex, body mass index, smoking, and insulin resistance index. The present findings suggest that the beta(3)-AR gene polymorphism plays a role in the genetic predisposition to increased sdLDL, independently of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998022     DOI: 10.1016/j.metabol.2007.07.012

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects.

Authors:  Kazuhiko Kotani; Naoki Sakane; Masashi Ueda; Shinichi Mashiba; Yasuyuki Hayase; Kokoro Tsuzaki; Toshiyuki Yamada; Alan T Remaley
Journal:  Clin Chim Acta       Date:  2012-09-06       Impact factor: 3.786

2.  The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Naoki Sakane; Nobuyuki Taniguchi
Journal:  J Clin Med Res       Date:  2012-05-15

3.  LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Nobuyuki Taniguchi; Naoki Sakane
Journal:  Int J Prev Med       Date:  2012-03

4.  The association of the Clock 3111 T/C SNP with lipids and lipoproteins including small dense low-density lipoprotein: results from the Mima study.

Authors:  Kokoro Tsuzaki; Kazuhiko Kotani; Yoshiko Sano; Shinji Fujiwara; Kaoru Takahashi; Naoki Sakane
Journal:  BMC Med Genet       Date:  2010-10-21       Impact factor: 2.103

5.  Associations between Dietary Patterns, ADRβ2 Gln27Glu and ADRβ3 Trp64Arg with Regard to Serum Triglyceride Levels: J-MICC Study.

Authors:  Hinako Nanri; Yuichiro Nishida; Kazuyo Nakamura; Keitaro Tanaka; Mariko Naito; Guang Yin; Nobuyuki Hamajima; Naoyuki Takashima; Sadao Suzuki; Yora Nindita; Michiko Kohno; Hirokazu Uemura; Teruhide Koyama; Satoyo Hosono; Haruo Mikami; Michiaki Kubo; Hideo Tanaka
Journal:  Nutrients       Date:  2016-09-06       Impact factor: 5.717

Review 6.  Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches.

Authors:  Dragana Nikolic; Niki Katsiki; Giuseppe Montalto; Esma R Isenovic; Dimitri P Mikhailidis; Manfredi Rizzo
Journal:  Nutrients       Date:  2013-03-18       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.